Medicare Policy Tweak on LVADs May Reduce Access to Transplant Medicare Policy Tweak on LVADs May Reduce Access to Transplant
Advanced heart failure patients who receive an LVAD at a center without a transplant program may be less apt to receive a heart transplant.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - January 19, 2023 Category: Transplant Surgery Tags: Cardiology News Source Type: news
Smart stethoscope uses artificial intelligence to screen for heart failure
In this study, researchers used a familiar stethoscope (to listen to heart sounds) with additional sensors to record an ECG (an electrocardiogram, a measure of the heart ' s electrical activity). They incorporated artificial intelligence (a computer programme) to analyse the ECG reading.
The smart stethoscope identified people with heart failure correctly 9 out of 10 times. Few were missed by the stethoscope, and few were incorrectly identified as having heart failure when they did not.
The researchers say the tool could be used to diagnose heart failure earlier, in primary care. It could help GPs prioritise referrals to...
Source: Current Awareness Service for Health (CASH) - January 18, 2023 Category: Consumer Health News Source Type: news
Tunisia: Successful Heart Transplant Performed At Rabta Hospital in Tunis
[Tunis Afrique Presse] Tunis/Tunisia -- Medical and paramedical teams on Saturday successfully performed a heart transplant. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 9, 2023 Category: African Health Source Type: news
Tuning in to Your Most-Ignored Sense Can Make You Happier
Somewhere along the long, winding road of evolution, a bunch of genes got together in a conference room and decided it would probably be most optimal for human survival if we were forced to take in every sound all around us at all times. Thus, the ear was born. Unlike their neighbors the eyes, the ears came with no on/off option. This is a great safety feature if you’re living in a cave surrounded by predators, but it’s since been hijacked by a world in which you’re more likely to find yourself trying to sleep through a neighbor’s car alarm blaring at 1 A.M.
[time-brightcove not-tgx=”trueR...
Source: TIME: Health - January 6, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Mental Health Wellbeing Source Type: news
Fixing Heart Failure Workforce Issues: Baby Steps Start This Year
(MedPage Today) -- This spring, discussions on how to build a workforce that better meets the needs of the heart failure population will begin in earnest.
The alarming number of unfilled fellowship spots for advanced heart failure and transplant... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - January 5, 2023 Category: Urology & Nephrology Source Type: news
Alaska man misses lifesaving heart transplant surgery after winter storm cancels flight to Seattle, report says
An information board shows canceled flights on December 22, 2022, as the winter storm wreaked havoc on travel plans. JEFF KOWALSKY/AFP via Getty Images A man in his 50s had an eight-hour window to get from Alaska to Seattle for a heart transplant. His flights were canceled because of the massive…#seattle #alaskaairlines #alaska #holland #patrickholland #anchorage #patrick #fairbanks #heartinstitute #king5 (Source: Reuters: Health)
Source: Reuters: Health - December 31, 2022 Category: Consumer Health News Source Type: news
AI could boost x-ray's performance for diagnosing aortic dissection
An artificial intelligence (AI) algorithm could boost the performance of x-ra...Read more on AuntMinnie.comRelated Reading:
AI chest x-ray algorithm shows promise for emergency department reads
AI improves lung nodule detection in health screening
AI may aid fracture detection in osteoporotic patients
AI model predicts heart disease risk from x-rays
New study questions reliability of bone age AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 22, 2022 Category: Radiology Source Type: news
AHA News: Heart Transplant Recipient Honors Her Donor'By Living the Best Possible Life I Can '
TUESDAY, Dec. 20, 2022 (American Heart Association News) -- Even now, years later, Linda Jara ' s voice resonates with notes that can only be fully appreciated by certain people– people like her who carry someone else ' s heart.
Her tone is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 20, 2022 Category: General Medicine Source Type: news
NHS hopes new artificial intelligence software will be able to spot damage in heart scans in seconds
The new software, called AI segmentation and developed by researchers at the University of Sheffield Medical School, can do the job in under 60 seconds. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2022 Category: Consumer Health News Source Type: news
Science ’s 2022 Breakthrough of the Year: A telescope’s golden eye sees the universe anew
html { scroll-behavior: smooth; } .news-article-content--featured>.bodySection>.mb-2x:not(:first-of-type) { display: none; } h3 { scroll-margin-top: 5rem; } .parent-section h3, .subsection h3 { font-size: 1.375rem; line-height: 1.875rem; } .news-article-content-footer h2 { display: none; } .toc img { padding-bottom: 16px; transition: opacity .25s; } .toc img:hover { opacity: 60%; } .toc .image-grid img { padding-bottom: 16px; padding-top: 16px; } .image-grid .news-article__figure__image__wrapper:before, .image-grid .news-article__figure__image__wrapper:after { display: none; } .news-article...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news
Roche announces U.S. collaboration with Pfizer to help patients who test positive for COVID-19 navigate risks, symptoms, testing and treatment options
Testing early for COVID-19 can help determine the proper course of treatment.This collaboration helpspatients access critical resources and locate information about testing, available treatment options, high-risk factors that increase the chance of progressing to severe COVID-19, and ways to seek timely care.The Pilot ® COVID-19 At-Home Test will now include a QR code that directs individuals tocovid19knowmore.com, a Pfizer website, to learn more about testing and treatment options.Basel, 14 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has entered into a U.S. focused collaboration with Pfizer to d...
Source: Roche Media News - December 14, 2022 Category: Pharmaceuticals Source Type: news
A few bad apples or a whole rotten barrel? EU wrestles with corruption scandal
Press play to listen to this article Voiced by artificial intelligence. As Belgian police launched a second wave of raids on the European Parliament, a stunned Brussels elite has started to grapple with an uncomfortable question at the heart of the Qatar bribery investigation: Just how deep does…#brusselspresscorps #qatar #socialists #qatari #greens #michielvanhulten #worldcup #europeanparliament #santercommission #leyen (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2022 Category: Consumer Health News Source Type: news
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX ® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
NEW ORLEANS, December 12, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating progression-free survival (PFS), minimal residual disease (MRD) negativity and overall response rate (ORR) at a median follow-up of 64.5 months, and overall survival (OS) at a median follow-up of 73.6 months in newly diagnosed, transplant-ineligible (TIE) patients with multiple myeloma, regardless of patients’ age and across clinically important subgroups, as well as health...
Source: Johnson and Johnson - December 12, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Janssen Presents First Data from MajesTEC-2 Trial of TECVAYLI ™ (teclistamab-cqyv) in Combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and Lenalidomide in Relapsed or Refractory Multiple Myeloma
NEW ORLEANS, December 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from a cohort of the Phase 1b MajesTEC-2 study of TECVAYLI™ (teclistamab-cqyv), a first-in-class, BCMAxCD3 bispecific T-cell engager antibody, in combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and lenalidomide. According to the results, the immune-based triplet therapy regimen had a manageable safety profile with no unexpected safety signals observed. A very good partial response (VGPR) or better was achieved by 90.3 percent of patients with relapsed or refractory multiple ...
Source: Johnson and Johnson - December 10, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
AI chest x-ray algorithm shows promise for emergency department reads
An artificial intelligence (AI) algorithm that provided readings on bedsid...Read more on AuntMinnie.comRelated Reading:
AI improves lung nodule detection in health screening
AI may aid fracture detection in osteoporotic patients
Video from RSNA 2022: AI implementation trends
How to avoid the AI integration traps
AI model predicts heart disease risk from x-rays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 9, 2022 Category: Radiology Source Type: news
